Newsletter May 2016 No.173
Top News
Second Meeting of Code Compliance Managers/Practicing Managers
The 2nd Meeting of Code and Compliance Managers/Practicing Managers was held on March 10, 2016 at Bellesalle Tokyo Nihonbashi with the following program (Table 1). This year's meeting consisted of three parts: morning session, first afternoon session, and second afternoon session, and was conducted in a different format than in the past, including a group discussion session. In total, 200 code compliance managers/practitioners from 72 companies participated in the three sessions.
Topics
- 2016 Life Science IP Forum" co-hosted with Bioindustry Association of Japan
- The Pharmaceutical Manufacturers Association of Japan (PMAJ) held the "Forum on Pharmaceutical Consultation and Response".
- Held a briefing session on "Cost-Effectiveness Evaluation
- Held "Pharmaceutical Association Media Forum" -How far have we moved? Immunization System and Countermeasures against Infectious Diseases
- The Pharmaceutical Manufacturers Association of Japan (PMAJ) held the "PMAJ Media Forum" on the theme of "The Latest Cancer Therapy -Cancer Immunotherapy
- The 18th Pharmaceutical Quality Forum Symposium was held.
- Held the 7th Workshop on Environmental Technology
- The 3rd Japan-Thailand Joint Symposium was held.
- Proposal for the G7 Ise-Shima Summit by the Pharmaceutical Manufacturers Association of Japan
- Report on the APEC LSIF-RHSC Peru Meeting: APAC RA-EWG Activities Contribute to the Promotion of Regulatory Convergence in the APEC Region
- Sharing Subject-Level Data from Clinical Trials - Being a Modern Pharmaceutical Company - Clinical Trial Disclosure Programs are Essential
Contributions
Policy Research Institute page
Citizens, Patients and Musubu
Lecture for member companies by Dr. Kaori Muto, University of Tokyo
From JPMA
Bringing Innovative New Medicines to the People of Asia